The pharmacokinetic profiles of naproxen in blood and synovial fluid (SF) following topical and i.v. bolus administration in dogs, and the local tissue disposition of the drug following topical and oral administration in rats, were investigated to assess the feasibility of topical delivery of naprox
Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats
β Scribed by Daryl J. Fediuk; Tao Wang; Yufei Chen; Fiona E. Parkinson; Michael P. Namaka; Keith J. Simons; Frank J. Burczynski; Xiaochen Gu
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 244 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.765
No coin nor oath required. For personal study only.
β¦ Synopsis
The insect repellent N,N-diethyl-m-toluamide (DEET) and sunscreen oxybenzone (OBZ) have been shown to produce synergistic permeation enhancement when applied concurrently in vitro and in vivo. The disposition of both compounds following intravenous administration (2mg/ kg of DEET or OBZ) and topical skin application (100mg/kg of DEET and 40mg/kg of OBZ) was determined in male Sprague-Dawley rats. Pharmacokinetic analysis was also conducted using compartmental and non-compartmental methods. A two-compartment model was deemed the best fit for intravenous administration. The DEET and oxybenzone permeated across the skin to accumulate in blood, liver and kidney following topical skin application. Combined use of DEET and oxybenzone accelerated the disappearance of both compounds from the application site, increased their distribution in the liver and significantly decreased the apparent elimination half-lives of both compounds (p<0.05). Hepatoma cell studies revealed toxicity from exposure to all treatment concentrations, most notably at 72 h. Although DEET and oxybenzone were capable of mutually enhancing their percutaneous permeation and systemic distribution from topical skin application, there was no evidence of increased hepatotoxic deficits from concurrent application.
π SIMILAR VOLUMES
## Abstract Unlike __d__βalpha tocopherol (T), __d__βalpha tocopheryl succinate (TS) has the unique ability to selectively kill tumor cells while protecting normal tissue from toxic oxidative stress. The pharmacokinetics of TS and the serum and tissue disposition of TS were studied in male Spragueβ